|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
13.66(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$206.89 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
775,132 |
1,954,537 |
3,671,939 |
3,760,365 |
Total Sell Value |
$315,716,326 |
$777,957,532 |
$1,216,956,934 |
$1,236,631,446 |
Total People Sold |
5 |
6 |
8 |
8 |
Total Sell Transactions |
29 |
58 |
97 |
104 |
End Date |
2024-03-02 |
2023-11-30 |
2023-06-01 |
2022-06-01 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Medpace Investors, Llc |
10% Owner |
|
2022-09-06 |
4 |
AB |
$147.59 |
$8,347,248 |
D/D |
56,557 |
5,660,986 |
|
60% |
|
Troendle August J. |
CEO |
|
2022-09-02 |
4 |
AB |
$144.98 |
$7,062,556 |
I/I |
48,714 |
5,604,429 |
|
57% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-02 |
4 |
AB |
$144.98 |
$7,062,556 |
D/D |
48,714 |
5,604,429 |
|
57% |
|
Troendle August J. |
CEO |
|
2022-09-01 |
4 |
AB |
$144.52 |
$6,080,824 |
I/I |
42,076 |
5,555,715 |
|
55% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-09-01 |
4 |
AB |
$144.52 |
$6,080,824 |
D/D |
42,076 |
5,555,715 |
|
55% |
|
Troendle August J. |
CEO |
|
2022-07-18 |
4 |
AB |
$145.00 |
$1,207,850 |
I/I |
8,330 |
5,513,639 |
|
46% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-07-18 |
4 |
AB |
$145.00 |
$1,207,850 |
D/D |
8,330 |
5,513,639 |
|
46% |
|
Troendle August J. |
CEO |
|
2022-07-14 |
4 |
AB |
$144.59 |
$3,222,911 |
I/I |
22,290 |
5,505,309 |
|
48% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-07-14 |
4 |
AB |
$144.59 |
$3,222,911 |
D/D |
22,290 |
5,505,309 |
|
48% |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2022-05-06 |
4 |
OE |
$32.05 |
$32,050 |
D/D |
1,000 |
14,854 |
|
- |
|
Troendle August J. |
CEO |
|
2022-03-01 |
4 |
OE |
$90.65 |
$9,065,000 |
D/D |
100,000 |
806,643 |
|
- |
|
Burwig Susan E |
Exec. VP, Operations |
|
2022-02-23 |
4 |
OE |
$28.32 |
$351,168 |
D/D |
12,400 |
20,183 |
|
- |
|
Davenport Fred B Jr |
Director |
|
2022-02-17 |
4 |
B |
$145.80 |
$72,900 |
I/I |
500 |
2,000 |
2.1 |
5% |
|
Troendle August J. |
CEO |
|
2022-01-04 |
4 |
AS |
$213.44 |
$712,463 |
I/I |
(3,338) |
5,483,019 |
|
-32% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-01-04 |
4 |
AS |
$213.44 |
$712,463 |
D/D |
(3,338) |
5,483,019 |
|
-32% |
|
Troendle August J. |
CEO |
|
2022-01-03 |
4 |
AS |
$212.70 |
$4,199,549 |
I/I |
(19,744) |
5,486,357 |
|
-38% |
|
Medpace Investors, Llc |
10% Owner |
|
2022-01-03 |
4 |
AS |
$212.70 |
$4,199,549 |
D/D |
(19,744) |
5,486,357 |
|
-38% |
|
Troendle August J. |
CEO |
|
2021-12-31 |
4 |
AS |
$219.14 |
$2,863,941 |
I/I |
(13,069) |
5,506,101 |
|
-40% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-31 |
4 |
AS |
$219.14 |
$2,863,941 |
D/D |
(13,069) |
5,506,101 |
|
-40% |
|
Troendle August J. |
CEO |
|
2021-12-30 |
4 |
AS |
$220.34 |
$3,828,628 |
I/I |
(17,376) |
5,519,170 |
|
-39% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-30 |
4 |
AS |
$220.34 |
$3,828,628 |
D/D |
(17,376) |
5,519,170 |
|
-39% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-29 |
4 |
AS |
$220.16 |
$3,687,680 |
D/D |
(16,750) |
5,536,546 |
|
-41% |
|
Troendle August J. |
CEO |
|
2021-12-29 |
4 |
AS |
$220.16 |
$3,687,680 |
I/I |
(16,750) |
5,536,546 |
|
-41% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-28 |
4 |
AS |
$222.18 |
$5,358,537 |
D/D |
(24,118) |
5,553,296 |
|
-38% |
|
Troendle August J. |
CEO |
|
2021-12-28 |
4 |
AS |
$222.18 |
$5,358,537 |
I/I |
(24,118) |
5,553,296 |
|
-38% |
|
247 Records found
|
|
Page 2 of 10 |
|
|